Last updated: Nov 7, 2025
This roundtable highlights India’s biopharma sector and explores key strategies to boost and support its biopharma ecosystem.
Overview
New technologies are revolutionizing drug discovery worldwide. However, e ciently exploiting these technological advances to develop new drugs and get them to patients can be extremely challenging. Many stakeholders play signi cant roles in this complex process, including academic researchers, industry, government agencies, industry, and more.
“Mainstreaming some of the new age therapies and emerging technologies will require the whole ecosystem to go along – integrated data platforms, the funding environment, streamlining regulatory pathways, the patents system, addressing payer dynamics, etc.” – Anju Ghangurde, Citeline
As India strives to become a larger player in the biopharma sector moving from cost-based to value and innovation-based growth, experts are focusing on addressing a variety of issues like collaborative research, funding mechanisms, the regulatory environment, and the clinical trial infrastructure. To focus greater attention and resources, and to generate increased momentum in support of the sector, industry and government leaders have developed long-term targets to promote and accelerate biopharma innovation
